Shawn Kwatra is a Dermatology physician affiliated with University of Maryland, Baltimore. OpenAlex indexes 523 publications with 7,908 citations (h-index 50); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Dermatology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
601 N Caroline St Ste 8065
Baltimore, MD 212870006
Telephone
410-955-5933Registry record last updated 13 Mar 2019.
Clinical trials
- Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin
Sponsor: Johns Hopkins University
- Analysis of Reporting of Cutaneous Toxicities Associated With Immune Checkpoint Inhibitors
Sponsor: Johns Hopkins University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year202518 payments$66,090openpaymentsdata.cms.gov ↗
- Eli Lilly and CompanyProgram year20257 payments$15,480openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202514 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
55.3%Azole Antifungal31.9%Ketoconazole100%Part D<11 patientsLincosamide Antibacterial23.4%Clindamycin Phosphate100%Part D<11 patientsDermatology
44.7%Corticosteroid44.7%Triamcinolone Acetonide100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2021–2025 per NIH RePORTER. The latest:
- Racial Differences in Biomarkers and Therapeutic Targets for Chronic Itch
University of Maryland Baltimore
FY2025$171,072K23AR077073 - Racial Differences in Biomarkers and Therapeutic Targets for Chronic Itch
University of Maryland Baltimore
FY2024$171,072K23AR077073 - Racial Differences in Biomarkers and Therapeutic Targets for Chronic Itch
Johns Hopkins University
FY2023$177,120K23AR077073
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prurigo nodularis: new insights into pathogenesis and novel therapeutics
British Journal of Dermatology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Kittner
University of Maryland, Baltimore
Edward Sausville, MD
University of Maryland, Baltimore
Aloke Finn, MD
University of Maryland, Baltimore
Christopher Plowe, MD
University of Maryland, Baltimore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”